Publications by authors named "Quentin Devin"

Claim this Profile
D
Discontinuation versus continuation of imatinib in patients with advanced gastrointestinal stromal tumours (BFR14): exploratory long-term follow-up of an open-label, multicentre, randomised, phase 3 trial.
Jean-Yves Blay, Quentin Devin, Florence Duffaud, Maud Toulmonde, Nelly Firmin

Lancet Oncolยท September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis